Covered recipient · General Payments record
JEROME RAMOS-ESTEBAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2022–2024
$2,900.39
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,446.87 | 3 |
| Food and Beverage | $1,358.07 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $1,849.79 | 6 |
| Amgen Inc. | $447.94 | 16 |
| ABBVIE INC. | $238.29 | 2 |
| Ocular Therapeutix, Inc. | $120.90 | 1 |
| Bausch & Lomb Americas Inc. | $120.55 | 2 |
| Tarsus Pharmaceuticals, Inc. | $27.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $120.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105368774 | CMS |
| ABBVIE INC. | $118.29 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105368777 | CMS |
| Alcon Vision LLC | $24.08 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718867 | CMS |
| Alcon Vision LLC | $207.71 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529936 | CMS |
| Alcon Vision LLC | $224.96 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529938 | CMS |
| Alcon Vision LLC | $1,014.20 | 05/03/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110529940 | CMS |
| Alcon Vision LLC | $293.84 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718871 | CMS |
| Alcon Vision LLC | $85.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110718869 | CMS |
| Amgen Inc. | $12.88 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683881 | CMS |
| Amgen Inc. | $17.07 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683877 | CMS |
| Amgen Inc. | $22.08 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683885 | CMS |
| Amgen Inc. | $29.15 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683889 | CMS |
| Amgen Inc. | $17.90 | 05/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683894 | CMS |
| Amgen Inc. | $77.72 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683902 | CMS |
| Amgen Inc. | $12.54 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683898 | CMS |
| Amgen Inc. | $19.40 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683907 | CMS |
| Amgen Inc. | $12.02 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683911 | CMS |
| Amgen Inc. | $15.52 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683915 | CMS |
| Amgen Inc. | $18.91 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683919 | CMS |
| Amgen Inc. | $14.55 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683924 | CMS |
| Amgen Inc. | $21.61 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683928 | CMS |
| Amgen Inc. | $21.61 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683932 | CMS |
| Amgen Inc. | $124.98 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683941 | CMS |
| Amgen Inc. | $10.00 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111683936 | CMS |
| Bausch & Lomb Americas Inc. | $101.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140367487 | CMS |
| Bausch & Lomb Americas Inc. | $18.71 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140367489 | CMS |
| Ocular Therapeutix, Inc. | $120.90 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148199597 | CMS |
| Tarsus Pharmaceuticals, Inc. | $27.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139126446 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.